RYTM - RHYTHM PHARMACEUTICALS, INC.
93.52
2.060 2.203%
Share volume: 629,258
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$91.46
2.06
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-06-2024 | 02-28-2025 | 05-07-2025 | 08-05-2025 | 11-04-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 258.651 M | 381.846 M | 363.572 M | 392.273 M | 386.685 M | 372.733 M | 506.874 M | 480.196 M | |
| Current Assets | 235.753 M | 357.366 M | 340.341 M | 374.200 M | 369.288 M | 360.680 M | 494.802 M | 466.916 M | |
| Inventories | 8.507 M | 11.994 M | 13.895 M | 18.741 M | 19.316 M | 18.872 M | 22.107 M | 25.753 M | |
| Other Current Assets | 11.352 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 11.352 M | 157.461 M | 250.869 M | 231.428 M | 208.393 M | 155.444 M | 363.974 M | 334.648 M | |
| Total Receivables | 14.695 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 201.199 M | 161.669 M | 47.521 M | 89.137 M | 106.095 M | 135.586 M | 52.078 M | 54.301 M | |
| Total Non-current Assets | 22.898 M | 12.750 M | 11.992 M | 7.326 M | 7.144 M | 2.220 M | 2.473 M | 3.286 M | |
| Property Plant Equipment | 1.149 M | 973.000 K | 801.000 K | 632.000 K | 462.000 K | 297.000 K | 237.000 K | 1.104 M | |
| Other Assets | 14.474 M | 23.047 M | 21.968 M | 16.977 M | 16.471 M | 11.229 M | 11.164 M | 11.654 M | |
| Intangible Assets | 6.815 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 258.651 M | 381.846 M | 363.572 M | 392.273 M | 386.685 M | 372.733 M | 506.874 M | 480.196 M | |
| Total liabilities | 197.070 M | 202.351 M | 210.876 M | 227.724 M | 223.596 M | 239.150 M | 211.191 M | 210.170 M | |
| Total current liabilities | 54.160 M | 54.722 M | 97.605 M | 115.517 M | 111.823 M | 129.455 M | 104.267 M | 105.942 M | |
| Accounts Payable | 7.550 M | 4.543 M | 4.887 M | 12.328 M | 11.912 M | 15.982 M | 13.631 M | 13.947 M | |
| Other liabilities | 35.258 M | 38.897 M | 4.030 M | 3.938 M | 3.839 M | 3.681 M | 3.515 M | 3.342 M | |
| Current long term debt | 793.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 107.652 M | 0.000 | 0.000 | 108.269 M | 107.934 M | 106.014 M | 103.409 M | 100.886 M | |
| Other liabilities | 35.258 M | 38.897 M | 4.030 M | 3.938 M | 3.839 M | 3.681 M | 3.515 M | 3.342 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 61.581 M | 39.343 M | 11.215 M | 21.729 M | 18.947 M | -11.908 M | 148.817 M | 139.069 M | |
| Common stock | 60.144 M | 1.108 B | 1.124 B | 1.177 B | 1.224 B | 1.242 B | 1.454 B | 1.492 B | |
| Retained earnings | -1.036 B | -1.068 B | -1.112 B | -1.155 B | -1.205 B | -1.251 B | -1.304 B | -1.352 B |